QA: Vyant Bio Inc in us_health_services/2018

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001349929_2019_Vyant_Bio_Inc.pdf

Logs

warning The stock price does not exist industry.us_generic {}
info Minor missing amount for aggregate added to remainder industry.us_generic {'aggregate': 'Expenses', 'missing_ratio': 0.0021560328994649843, 'aggregate_val': 12496000, 'exp_sum': 12523000, 'exp_to_value': {'LaborExpense': 0, 'CostOfGoodsAndServicesSold': 3701000, 'GeneralAndAdministrativeExpense': 5171000, 'GoodwillImpairmentLoss': 2900000, 'OperatingCostsAndExpenses': 0, 'DepreciationDepletionAndAmortization': 0, 'SellingAndMarketingExpense': 1146000, 'ResearchAndDevelopmentExpense': 0, 'remainder_Expenses': -395000}}
info Minor missing amount for aggregate added to remainder industry.us_generic {'aggregate': 'Assets', 'missing_ratio': 0.32475534613990575, 'aggregate_val': 14904000, 'exp_sum': 22072000, 'exp_to_value': {'IntangibleAssets': 5985000, 'AssetsNonCurrent': 7168000, 'AssetsCurrent': 7178000, 'PropertyPlantAndEquipment': 558000, 'remainder_Assets': 1183000}}
info Minor missing amount for aggregate added to remainder industry.us_generic {'aggregate': 'Assets', 'missing_ratio': 0.3832674319357592, 'aggregate_val': 35406000, 'exp_sum': 57409000, 'exp_to_value': {'IntangibleAssets': 17257000, 'AssetsNonCurrent': 22003000, 'AssetsCurrent': 9347000, 'PropertyPlantAndEquipment': 4056000, 'remainder_Assets': 4746000}}
info Failed to set obs_EconomicCapitalRatio industry.us_generic {'reason': "KeyError('0001349929')"}

Graph

Absolute values for 0001349929, Vyant Bio Inc

  xvar xval
0 IntangibleAssets 17,257,000
1 AssetsNonCurrent 22,003,000
2 AssetsCurrent 9,347,000
3 PropertyPlantAndEquipment 4,056,000
4 remainder_Assets -17,257,000
5 LongTermLiabilities 0
6 LiabilitiesCurrent 27,293,000
7 remainder_Liabilities 1,311,000
8 LaborExpense 0
9 CostOfGoodsAndServicesSold 18,724,000
10 GeneralAndAdministrativeExpense 19,184,000
11 GoodwillImpairmentLoss 0
12 OperatingCostsAndExpenses 0
13 DepreciationDepletionAndAmortization 0
14 SellingAndMarketingExpense 5,268,000
15 ResearchAndDevelopmentExpense 2,488,000
16 remainder_Expenses 3,784,000
17 remainder_Revenues 27,470,000
18 remainder_NetIncome 1,605,000
19 remainder_ComprehensiveNetIncome -9,000
  yvar yval
0 Assets 35,406,000
1 Liabilities 28,604,000
2 Expenses 49,448,000
3 Revenues 27,470,000
4 StockholdersEquity 6,802,000
5 NetIncome -20,373,000
6 ComprehensiveNetIncome -20,382,000
7 BaseVar 71,271,000
8 EconomicCapitalRatiobeforeLimitedLiability -0.329
9 EconomicCapitalRatio 0.855

Edgar->Model Mapping

Feature Distribution

Change over Time